An EU official says the European Commission is seeking approval by member states to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, as reported in the Financial Post.
The official indicated that the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.
A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.
He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.
The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official added.
To read more NewsPoints articles, click here.